Expert Opinion on Therapeutic Patents logo Informa Healthcare logo

Publisher: Informa Healthcare

More about this publication?
Related content
Volume 18, Number 7, July 2008

< previous issue | all issues | next issue >



Nerve growth factor and brain-derived neurotrophic factor: potential targets for migraine treatment?
pp. 705-721(17)
Authors: Sarchielli, Paola; Nardi, Katiuscia; Mancini, Maria Luisa; Corbelli, Ilenia; Tambasco, Nicola; Chiasserini, Davide; Calabresi, Paolo

The development of novel therapies for rheumatoid arthritis
pp. 723-738(16)
Authors: Quan, Ling-dong; Thiele, Geoffrey M; Tian, Jun; Wang, Dong

Cancer cachexia: drugs in the patent literature
pp. 739-757(19)
Authors: Bossola, Maurizio; Pacelli, Fabio; Doglietto, Giovan Battista

Glucokinase activators as new type 2 diabetes therapeutic agents
pp. 759-768(10)
Authors: Sarabu, Ramakanth; Berthel, Steven J; Kester, Robert F; Tilley, Jefferson W

Fast-dissolving intra-oral drug delivery systems
pp. 769-781(13)
Authors: Saigal, Nitin; Baboota, Sanjula; Ahuja, Alka; Ali, Javed

Annotated Patent Selections

Annotated Patent Selections
pp. 783-795(13)

Patent Evaluations

Further improvements in the technology of HSV-1-based amplicon vectors
pp. 797-804(8)
Authors: Cuchet, Delphine; Epstein, Alberto L


Cell-targeted p38 inhibitors
pp. 805-809(5)
Author: Norman, Peter


pp. 811-811(1)

< previous issue | all issues | next issue >


Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page